Review




Structured Review

Sentinella Pharmaceuticals Inc sentinel lymph node biopsy
Sentinel Lymph Node Biopsy, supplied by Sentinella Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/biopsy+lymph+node+sentinel/pm41634779-388-21-36
Average 86 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

Dissection:

Article Title: Anatomical location of metastatic sentinel lymph node and clinicopathological characteristics for predicting risk of non-sentinel lymph node metastasis.
Article Snippet: .. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. ..

Article Title: Treatment of the axila in breast cancer surgery: Systematic review of its impact on survival.
Article Snippet: Sentinel lymph node biopsy and ACOSOG-Z0011 criteria have modified axillary treatment in breast cancer surgery.. We performed a systematic review of studies assessing the impact of axillary treatment on survival.. The search showed 6891 potentially eligible items.

Article Title: [Fluorescence lymphography for sentinal lymph node biopsy in breast cancer].
Article Snippet: Objective.. To study diagnostic value of fluorescence lymphography for sentinel lymph node biopsy in breast cancer.. Material and methods.

Article Title: Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review.
Article Snippet: A remarkably consistent local control benefit has been demonstrated in multiple randomized phase 3 studies designed to assess the role of adjuvant radiotherapy (RT) in women treated with breastconserving surgery.. These trials1-11 (Table 1), initiated over 2 decades (1976-1991), included a variety of surgical managements, systemic treatments, radiation doses and fields, and baseline recurrence risks.. Despite these differences, all trials demonstrated a strikingly similar risk reduction in the rates of local recurrence with the addition of adjuvant RT.

Article Title: SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes.
Article Snippet: Sentinel lymph node biopsy alone is the current surgical axillary treatment for early-stage breast cancer patients with a negative sentinel lymph node (SLN).. The possibility to omit axillary dissection also in presence of positive SLNs has been promoted by the American College of Surgeons Oncology Group (ASOCOG) Z0011 randomized trial.. Several limitations and evidences of potential selection bias made this trial fairly controversial.

Article Title: Quality of Life After Sentinel Lymph Node Biopsy Versus Complete Axillary Lymph Node Dissection in Early Breast Cancer: A 3-Year Follow-up Study
Article Snippet: .. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. ..

Article Title: Top 100 cited classical articles in sentinel lymph nodes biopsy for breast cancer
Article Snippet: .. 50 , Zavagno, G , A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer - Results of the sentinella/GIVOM trial , ANNALS OF SURGERY , 2008 , 239. .. 51 , Goyal, A , Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase , BREAST CANCER RESEARCH AND TREATMENT , 2006 , 235.

Article Title: The value of the intraoperative assessment of the SLN via frozen section in the post Z0011 era.
Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.



Similar Products

86
Sentinella Pharmaceuticals Inc sentinel lymph node biopsy
Sentinel Lymph Node Biopsy, supplied by Sentinella Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/biopsy+lymph+node+sentinel/pm41634779-388-21-36
Average 86 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
NSABP Foundation sentinel lymph node biopsy
Sentinel Lymph Node Biopsy, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymph+node+biopsy/pmc12159821-43-23-12
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Verlag GmbH sentinel lymph node mapping and biopsy
Sentinel Lymph Node Mapping And Biopsy, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymph+node+biopsy/pm40327185-11-60-34
Average 90 stars, based on 1 article reviews
sentinel lymph node mapping and biopsy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Aslan Pharmaceuticals avoid axillary sentinel lymph node biopsy after neoadjuvant chemotherapy (aslan) trial
Avoid Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy (Aslan) Trial, supplied by Aslan Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/avoid+axillary+sentinel+lymph+node+biopsy+after+neoadjuvant+chemotherapy++aslan++trial/pm40233520-71-23-25
Average 90 stars, based on 1 article reviews
avoid axillary sentinel lymph node biopsy after neoadjuvant chemotherapy (aslan) trial - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
NSABP Foundation sentinel lymph node biopsy (slnb)
Sentinel Lymph Node Biopsy (Slnb), supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymphadenectomy++slnb+/pm40188594-21-11-1
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy (slnb) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
NSABP Foundation sentinel lymph node biopsy (sln
Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c <t>—clinical.</t> <t>SLN—sentinel</t> lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.
Sentinel Lymph Node Biopsy (Sln, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymph+node+biopsy/pmc11545455-140-7-23
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy (sln - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Rambam Health Corporation sentinel lymph node biopsy
Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c <t>—clinical.</t> <t>SLN—sentinel</t> lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.
Sentinel Lymph Node Biopsy, supplied by Rambam Health Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sialendoscopy/pm38987034-22-2-12
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c —clinical. SLN—sentinel lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c —clinical. SLN—sentinel lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques: Dissection, Magnetic Resonance Imaging

Overall population demographics and distribution according to ALND results. Significant p values are reported in bold. a Only 2 cT4b patients fulfilled the inclusion criteria in the cT3/cT4 category; the remainder of the group is composed exclusively of cT3 patients. b For statistical analysis, RECIST criteria categories of progressive disease, stable disease and partial response have been aggregated into a non-complete response group. c Axillary US and breast/axillar MRI were performed at initial diagnosis in all patients included in the study, and breast/axillar MRI after NAC was also scheduled in all patients, except in 4 patients whose data are not available. List of abbreviations: ALND—axillary lymph node dissection;  SLN—sentinel  lymph node; SD—standard deviation; BMI—body mass index; MRI—magnetic resonance imaging; ER—estrogen receptor; PR—progesterone receptor; IHC—immunohistochemical; HR—hormonal receptor; TN—triple negative; NAC—neoadjuvant chemotherapy.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Overall population demographics and distribution according to ALND results. Significant p values are reported in bold. a Only 2 cT4b patients fulfilled the inclusion criteria in the cT3/cT4 category; the remainder of the group is composed exclusively of cT3 patients. b For statistical analysis, RECIST criteria categories of progressive disease, stable disease and partial response have been aggregated into a non-complete response group. c Axillary US and breast/axillar MRI were performed at initial diagnosis in all patients included in the study, and breast/axillar MRI after NAC was also scheduled in all patients, except in 4 patients whose data are not available. List of abbreviations: ALND—axillary lymph node dissection; SLN—sentinel lymph node; SD—standard deviation; BMI—body mass index; MRI—magnetic resonance imaging; ER—estrogen receptor; PR—progesterone receptor; IHC—immunohistochemical; HR—hormonal receptor; TN—triple negative; NAC—neoadjuvant chemotherapy.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques: Dissection, Imaging

Axillary surgery details according to ALDN results. Significant p values are reported in bold.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Axillary surgery details according to ALDN results. Significant p values are reported in bold.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques:

Patterns of SLN, SLN-R and non-SLN involvement at ALND. ( A ) Number of non-SLN affected at ALND, according to cN status at diagnosis and size of SLN metastasis in the overall population. ( B ) Pattern of non-SLN involvement after ALND, according to SLN-R cut-off ≤ 0.35. ( C ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 and size of SLN metastasis. ( D ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 within each IHC subtype. List of abbreviations: nRD—non-residual disease; RD—residual disease; IHC—immunohistochemistry; SLN—sentinel lymph node; ALND—axillary lymph node dissection; ITC—isolated tumor cells; Micro—micrometastases; Macro—macrometastases; HR—hormone receptor; + positive; − negative; TN—triple negative breast cancer. p values refer to Chi-squared tests.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Patterns of SLN, SLN-R and non-SLN involvement at ALND. ( A ) Number of non-SLN affected at ALND, according to cN status at diagnosis and size of SLN metastasis in the overall population. ( B ) Pattern of non-SLN involvement after ALND, according to SLN-R cut-off ≤ 0.35. ( C ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 and size of SLN metastasis. ( D ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 within each IHC subtype. List of abbreviations: nRD—non-residual disease; RD—residual disease; IHC—immunohistochemistry; SLN—sentinel lymph node; ALND—axillary lymph node dissection; ITC—isolated tumor cells; Micro—micrometastases; Macro—macrometastases; HR—hormone receptor; + positive; − negative; TN—triple negative breast cancer. p values refer to Chi-squared tests.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques: Immunohistochemistry, Dissection, Isolation